Howard J. Huang VIEW CLINICAL PROFILE

Howard J. Huang, MD

Associate Professor of Clinical Medicine, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Active Clinical Trials

A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

NCT03808922

Publications

A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation
Huang, HJ, Schechtman, K, Askar, M, Bernadt, C, Mitter, B, Dore, P, Goodarzi, A, Yau, SW, Youssef, JG, Witt, CA, Byers, DE, Vazquez-Guillamet, R, Halverson, L, Nava, R, Puri, V, Kreisel, D, Gelman, AE & Hachem, RR 2024, , Transplantation, vol. 108, no. 3, pp. 777-786. https://doi.org/10.1097/TP.0000000000004841

Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series
Halawi, H, Harris, JE, Goodarzi, A, Yau, S, Youssef, JG, Botros, M & Huang, HJ 2024, , Pharmacotherapy, vol. 44, no. 3, pp. 283-289. https://doi.org/10.1002/phar.2910

Enhanced recovery after surgery may mitigate the risks associated with robotic-assisted fundoplication in lung transplant patients
Wu, R, Robayo, V, Nguyen, DT, Chan, EY, Chihara, R, Huang, HJ, Graviss, EA & Kim, MP 2024, , Surgical Endoscopy, vol. 38, no. 4, pp. 2134-2141. https://doi.org/10.1007/s00464-024-10719-9

Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators
Wang, S, Niroula, S, Hoffman, A, Khorrami, M, Khorrami, M, Yuan, F, Gasser, GN, Choi, S, Liu, B, Li, J, Metersky, ML, Vincent, M, Crum, CP, Boucher, RC, Karmouty-Quintana, H, Huang, HJ, Sheshadri, A, Dickey, BF, Parekh, KR, Engelhardt, JF, McKeon, FD & Xian, W 2023, , American journal of respiratory and critical care medicine, vol. 208, no. 9, pp. 930-943. https://doi.org/10.1164/rccm.202305-0818OC

A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation
Huang, HJ, Schechtman, K, Askar, M, Bernadt, C, Mitter, B, Dore, P, Goodarzi, A, Yau, SW, Youssef, JG, Witt, CA, Byers, DE, Vazquez-Guillamet, R, Halverson, L, Nava, R, Puri, V, Kreisel, D, Gelman, AE & Hachem, RR 2024, , Transplantation, vol. 108, no. 3, pp. 777-786. https://doi.org/10.1097/TP.0000000000004841

Progress in Combined Liver-lung Transplantation at a Single Center
Connor, AA, Huang, HJ, Mobley, CM, Graviss, EA, Nguyen, DT, Goodarzi, A, Saharia, A, Yau, S, Hobeika, MJ, Suarez, EE, Moaddab, M, Brombosz, EW, Moore, LW, Yi, SG, Gaber, AO & Ghobrial, RM 2023, , Transplantation Direct, vol. 9, no. 5, pp. E1482. https://doi.org/10.1097/TXD.0000000000001482

Cloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis
Wang, S, Rao, W, Hoffman, A, Lin, J, Li, J, Lin, T, Liew, AA, Vincent, M, Mertens, TCJ, Karmouty-Quintana, H, Crum, CP, Metersky, ML, Schwartz, DA, Davies, PJA, Stephan, C, Jyothula, SSK, Sheshadri, A, Suarez, EE, Huang, HJ, Engelhardt, JF, Dickey, BF, Parekh, KR, McKeon, FD & Xian, W 2023, , Science translational medicine, vol. 15, no. 693, eabp9528, pp. eabp9528. https://doi.org/10.1126/scitranslmed.abp9528

Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension
Goel, K, Egersdorf, N, Gill, A, Cao, D, Collum, SD, Jyothula, SS, Huang, HJ, Sauler, M, Lee, PJ, Majka, S, Karmouty-Quintana, H & Petrache, I 2022, , Respiratory Research, vol. 23, no. 1, 349. https://doi.org/10.1186/s12931-022-02267-4

COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients
Sandoval, M, Nguyen, DT, Huang, HJ, Yi, SG, Ghobrial, RM, Gaber, AO & Graviss, EA 2022, , PLoS ONE, vol. 17, no. 12 December, e0279222. https://doi.org/10.1371/journal.pone.0279222

Hospitalization and survival of solid organ transplant recipients with coronavirus disease 2019: A propensity matched cohort study
Swan, JT, Rizk, E, Jones, SL, Nwana, N, Nicolas, JC, Tran, AT, Xu, J, Nisar, T, Menser, T, Yi, SG, Moore, LW, Huang, HJ, Ghobrial, RM, Gaber, AO & Knight, RJ 2022, , PLoS ONE, vol. 17, no. 12, e0278781, pp. e0278781. https://doi.org/10.1371/journal.pone.0278781, https://doi.org/10.1371/journal.pone.0278781

Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation
Jyothula, SSK, Peters, A, Liang, Y, Bi, W, Shivshankar, P, Yau, S, Garcha, PS, Yuan, X, Akkanti, B, Collum, S, Wareing, N, Thandavarayan, RA, Poli de Frias, F, Rosas, IO, Zhao, B, Buja, LM, Eltzschig, HK, Huang, HJ & Karmouty-Quintana, H 2022, , EBioMedicine, vol. 86, 104351, pp. 104351. https://doi.org/10.1016/j.ebiom.2022.104351, https://doi.org/10.1016/j.ebiom.2022.104351

Predicting a Positive Antibody Response after 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach with External Validation
Alejo, JL, Mitchell, J, Chiang, TPY, Chang, A, Abedon, AT, Werbel, WA, Boyarsky, BJ, Zeiser, LB, Avery, RK, Tobian, AAR, Levan, ML, Warren, DS, Massie, AB, Moore, LW, Guha, A, Huang, HJ, Knight, RJ, Gaber, AO, Ghobrial, RM, Garonzik-Wang, JM, Segev, DL & Bae, S 2022, , Transplantation, vol. 106, no. 10, pp. E452-E460. https://doi.org/10.1097/TP.0000000000004259

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
Sheshadri, A, Huang, HJ, Bashoura, L, Alousi, AM, Alkhunaizi, M, Sharifi, H & Hsu, JL 2022, , Blood Advances, vol. 6, no. 17, pp. 4984-4986. https://doi.org/10.1182/bloodadvances.2022008201

3'UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension
Tseng, V, Collum, SD, Allawzi, A, Crotty, K, Yeligar, S, Trammell, A, Ryan Smith, M, Kang, B-Y, Sutliff, RL, Ingram, JL, Jyothula, SSSK, Thandavarayan, RA, Huang, HJ, Nozik, ES, Wagner, EJ, Michael Hart, C & Karmouty-Quintana, H 2022, , Matrix Biology, vol. 111, pp. 53-75. https://doi.org/10.1016/j.matbio.2022.06.001

A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation
Huang, HJ, Schechtman, K, Askar, M, Bernadt, C, Mittler, B, Dore, P, Witt, C, Byers, D, Vazquez-Guillamet, R, Halverson, L, Nava, R, Puri, V, Gelman, A, Kreisel, D & Hachem, RR 2022, , American Journal of Transplantation, vol. 22, no. 7, pp. 1884-1892. https://doi.org/10.1111/ajt.17028

Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis
Wilson, C, Mertens, TCJ, Shivshankar, P, Bi, W, Collum, SD, Wareing, N, Ko, J, Weng, T, Naikawadi, RP, Wolters, PJ, Maire, P, Jyothula, SSK, Thandavarayan, RA, Ren, D, Elrod, ND, Wagner, EJ, Huang, HJ, Dickey, BF, Ford, HL & Karmouty-Quintana, H 2022, , JCI insight, vol. 7, no. 10, e142984. https://doi.org/10.1172/jci.insight.142984

Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation
Sheshadri, A, Sacks, NC, Healey, BE, Raza, S, Boerner, G & Huang, HJ 2022, , Clinical Therapeutics, vol. 44, no. 5, pp. 755-765.e6. https://doi.org/10.1016/j.clinthera.2022.03.011

Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
The IPF-PRO Registry Investigators 2022, , Lung, vol. 200, no. 1, pp. 11-18. https://doi.org/10.1007/s00408-021-00505-y

Correction to: Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort (Lung, (2022), 200, 1, (11-18), 10.1007/s00408-021-00505-y)
The IPF-PRO Registry Investigators 2022, , Lung, vol. 200, no. 1, pp. 19. https://doi.org/10.1007/s00408-022-00516-3

Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
The IPF-PRO Registry Investigators 2022, , Respiratory Research, vol. 23, no. 1, 3, pp. 3. https://doi.org/10.1186/s12931-021-01921-7

VIEW FULL PUBLICATIONS